Published in J Infect Dis on March 01, 1993
Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev (2005) 2.24
Human herpesvirus 6. Clin Microbiol Rev (1997) 1.91
Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol (2000) 1.44
U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A (1998) 1.39
Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification. J Clin Microbiol (2004) 1.24
Temporal mapping of transcripts in herpesvirus 6 variants. J Virol (1998) 1.24
Structure and transcription of an immediate-early region in the human herpesvirus 6 genome. J Virol (1994) 1.10
Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J Virol (2007) 1.08
Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol (1995) 1.08
Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol (1999) 1.04
Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol (1996) 1.02
CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci U S A (1997) 1.01
Functional identification and analysis of cis-acting sequences which mediate genome cleavage and packaging in human herpesvirus 6. J Virol (1998) 0.98
Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol (1993) 0.95
Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J Exp Med (1995) 0.95
Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry (2015) 0.94
Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol (1999) 0.90
Seroprevalence of cytomegalovirus among some voluntary blood donors at the 37 military hospital, accra, ghana. Ghana Med J (2006) 0.87
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev (1997) 0.85
Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells. J Virol (2004) 0.85
The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines. J Virol (2010) 0.84
Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis. J Clin Microbiol (2002) 0.84
Identification and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7. J Virol (1997) 0.82
Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol (2013) 0.80
Comparison of specific serological assays for diagnosing human herpesvirus 6 infection after liver transplantation. Clin Diagn Lab Immunol (2001) 0.78
Human herpesvirus-6 infections. Arch Dis Child (1996) 0.77
Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method. Eur J Clin Microbiol Infect Dis (1998) 0.77
Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human herpesvirus 6. J Clin Microbiol (1996) 0.77
High prevalence of infectious adeno-associated virus (AAV) in human peripheral blood mononuclear cells indicative of T lymphocytes as sites of AAV persistence. J Virol (2016) 0.76
Disease association and diagnosis of human herpesvirus 6. Can J Infect Dis (1994) 0.75
Enzyme-linked immunosorbent assay for detection of antibody to human herpesvirus 6. Clin Diagn Lab Immunol (1997) 0.75
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med (1994) 3.26
Disseminated active HHV-6 infections in patients with AIDS. Lancet (1994) 3.16
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med (1993) 2.85
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol (1994) 2.73
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
T-cell depletion of HLA-identical transplants in leukemia. Blood (1991) 2.25
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet (1989) 2.18
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood (1993) 2.12
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis (1995) 1.94
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet (1991) 1.84
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol (1997) 1.75
Performance of a BACTEC nonradiometric medium for pediatric blood cultures. J Clin Microbiol (1991) 1.74
Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6-associated bone marrow suppression in bone marrow transplant patients. Blood (1994) 1.74
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N Engl J Med (1994) 1.71
Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA (1993) 1.70
Bone-marrow transplantation for leukaemia. Lancet (1995) 1.60
Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med (1994) 1.59
Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis (1994) 1.57
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant (2004) 1.55
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood (1989) 1.52
Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J Infect Dis (1989) 1.52
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia (1990) 1.49
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA (1999) 1.49
Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood (1989) 1.46
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant (2001) 1.46
Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains. Blood (1992) 1.45
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Ann Intern Med (2000) 1.42
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
Studies on the liver to kidney switch of erythropoietin production. J Clin Invest (1981) 1.41
How best to analyse new strategies in bone marrow transplantation. Bone Marrow Transplant (1990) 1.39
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Cell surface phenotype of a cloned line of human natural killer cells. J Immunol (1982) 1.35
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science (1984) 1.34
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (2001) 1.34
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation (1987) 1.31
Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol (2007) 1.29
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29
Four-day incubation period for blood culture bottles processed with the Difco ESP blood culture system. J Clin Microbiol (1997) 1.27
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Partial purification and characterization of a polymannuronic acid depolymerase produced by a mucoid strain of Pseudomonas aeruginosa isolated from a patient with cystic fibrosis. Appl Environ Microbiol (1985) 1.23
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol (1996) 1.22
Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surg Oral Med Oral Pathol (1990) 1.19
Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet (1991) 1.19
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood (1992) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status. J Clin Microbiol (2004) 1.18
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant (2012) 1.17
Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR. J Clin Microbiol (2006) 1.17
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16
Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood (1981) 1.13
Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1999) 1.13
Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Ther (2004) 1.13
Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics (1992) 1.12
Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science (2001) 1.11
Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J Infect Dis (1990) 1.11
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation. Transplantation (1991) 1.11
Differential expression and regulation of the human CD8 alpha and CD8 beta chains. Tissue Antigens (1990) 1.08
Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis (2007) 1.08
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood (1992) 1.07
Identical-twin bone marrow transplants for leukemia. Ann Intern Med (1994) 1.07
Report from the International Bone Marrow Transplant Registry. Clin Transpl (1992) 1.06
Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J Immunol (1983) 1.06
Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol (1999) 1.05
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation. Bone Marrow Transplant (1993) 1.05
Detection of circulating Aspergillus fumigatus antigen in bone marrow transplant patients. J Lab Clin Med (1989) 1.05
Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
M241 (CD1) expression on B lymphocytes. J Immunol (1987) 1.04
Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988-1990 survey. Ann Intern Med (1992) 1.04
Reversible repression and activation of measles virus infection in neural cells. Proc Natl Acad Sci U S A (1982) 1.04
Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis. Diagn Microbiol Infect Dis (1987) 1.03
Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med (1996) 1.03